This is by far the best meal plan I found! It has flavor and variety, both of which I NEEDED in planning meals. My husband even ate all of this, and he tends to be picky. I did deviate from it more and more as the weeks went by to fit time and schedule and inspiration, but from the ingredients I got to match this plan, I had plenty to work with and was able to still feed us while following Whole30 guidelines and finish the program. Thanks so much for putting this together!!!!
Two friends and I discussed the article, and then one proposed something unbelievable: "We should do Whole30 together." After considering what Philipps' had to say about it, I decided to give it a try. Then Health editor in chief Lori Leibovich asked me to document my Whole30 experience with daily video diaries on Health Instagram stories, and I knew there was no turning back. I was about to do my first diet ever.
Ideally one should eat a wide variety of proteins from as many animal sources as possible. One need not and should not avoid fatty cuts of meat, particularly if consuming pastured sources. An often overlooked piece of the paleo diet in popular culture is an over-reliance on standard cuts of meat, at the expense of organ meats, bone broth and other collagen sources. For more information on the historical and practical aspects of consuming a more balanced protein intake, check out the Weston A. Price Foundation. If weight-loss is a goal, protein makes you feel satisfied between meals.
Annie Thorisdottir will become only the third athlete in history to reach 10 individual CrossFit Games appearances, joining Ben Smith and Becca Voigt. The current streak is 10 consecutive individual appearances held by Ben Smith. He had surgery earlier this year and still has a chance to qualify through a Sanctional. Camille Leblanc-Bazinet holds the second longest streak at nine and has the opportunity to tie Smith if she wins a Sanctional.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”